Stay updated with breaking news from Biologics Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington, DC (PRWEB) July 20, 2023 -- NDA Partners’ Vice President and General Manager, Eric Fish, announced today that Dr. Laura Salazar-Fontana, a
Washington, DC (PRWEB) September 07, 2022 -- NDA Partners’ General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global regulatory
03.03.2022 - Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021 with cash position of $219.6 million that is expected to fund operations into first quarter of 2024 BELTSVILLE, Md., March 03, 2022 (GLOBE ...
BELTSVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related